Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Winquist

Showing results (161-170 of 234) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapyAmirrtha Srikanthan, Ben Tran, Michel Beausoleil, et al.
European Urology Open Science|October 27, 2025
Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective TrialRui M Bernardino, Leyi B Yin, Katherine Lajkosz, et al.
World Journal of Urology|June 19, 2017
Dose dense MVAC prior to radical cystectomy: a real-world experienceHomayoun Zargar, Jay B Shah, Elisabeth E Fransen van de Putte, et al.
Clinical and Translational Science|February 23, 2021
Impact of pretreatment dihydropyrimidine dehydrogenase genotype-guided fluoropyrimidine dosing on chemotherapy associated adverse eventsTheodore J Wigle, Brandi L Povitz, Samantha Medwid, et al.
The Prostate|February 17, 2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North AmericaAnthony M Joshua, Neal D Shore, Fred Saad, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
Canadian consensus guidelines for the management of testicular germ cell cancerLori Wood, Christian Kollmannsberger, Michael Jewett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 27, 2022
Canadian Urological Association consensus guideline: Management of testicular germ cell cancerRobert J Hamilton, Christina Canil, Noa Shani Shrem, et al.
European Urology Oncology|January 31, 2023
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR StudyViktor Grünwald, Thomas Powles, Evgeny Kopyltsov, et al.
Oncotarget|June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell linesFarhad Ghasemi, Morgan Black, Ren X Sun, et al.
Trials|December 13, 2025
The SHARE study - Survivorship After Head and Neck Cancer: evaluating patient care and adherence to follow up in Ontario, Canada: study protocol for a randomized controlled trialBilly Tran, Agnieszka Dzioba, Jennifer Baker, et al.
Pageof 24

Showing results (161-170 of 234) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapyAmirrtha Srikanthan, Ben Tran, Michel Beausoleil, et al.
European Urology Open Science|October 27, 2025
Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective TrialRui M Bernardino, Leyi B Yin, Katherine Lajkosz, et al.
World Journal of Urology|June 19, 2017
Dose dense MVAC prior to radical cystectomy: a real-world experienceHomayoun Zargar, Jay B Shah, Elisabeth E Fransen van de Putte, et al.
Clinical and Translational Science|February 23, 2021
Impact of pretreatment dihydropyrimidine dehydrogenase genotype-guided fluoropyrimidine dosing on chemotherapy associated adverse eventsTheodore J Wigle, Brandi L Povitz, Samantha Medwid, et al.
The Prostate|February 17, 2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North AmericaAnthony M Joshua, Neal D Shore, Fred Saad, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
Canadian consensus guidelines for the management of testicular germ cell cancerLori Wood, Christian Kollmannsberger, Michael Jewett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 27, 2022
Canadian Urological Association consensus guideline: Management of testicular germ cell cancerRobert J Hamilton, Christina Canil, Noa Shani Shrem, et al.
European Urology Oncology|January 31, 2023
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR StudyViktor Grünwald, Thomas Powles, Evgeny Kopyltsov, et al.
Oncotarget|June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell linesFarhad Ghasemi, Morgan Black, Ren X Sun, et al.
Trials|December 13, 2025
The SHARE study - Survivorship After Head and Neck Cancer: evaluating patient care and adherence to follow up in Ontario, Canada: study protocol for a randomized controlled trialBilly Tran, Agnieszka Dzioba, Jennifer Baker, et al.
Pageof 24